OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia
NCT ID: NCT06430957
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
240 participants
OBSERVATIONAL
2024-06-28
2026-02-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Pulmonary Complications In Obstructive Sleep Apnea Patients
NCT06041750
The Effect of Intubation Without Muscle Relaxation on Post Operative Recovery Conditions: Double Blind Randomized Controlled Study
NCT03824470
Relationship Between STOP BANG Score and Airway Management
NCT05640856
Optimal Anesthesia for Morbidly Obese Patients
NCT04395248
Measuring Sleep Quality In Patients That Posterior Spinal Instrumentatıon Plannıng
NCT06269328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group lowSTOP-B
Study group including patients in the low-risk group in the assessment to be made with STOP-BANG questionnaire.
The STOP-BANG questionnaire for determining OSA risk level.
An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.
Record of postoperative complications
Respiratory complications as laryngospasm/bronchospasm, apnea, hypoxia, duration and amount of need for additional oxygen support and recovery time (duration of modified aldrete score of 9 and above) will be recorded.
Group intermediateSTOP-B
Study group including patients in the medium-risk group in the assessment to be made with STOP-BANG questionnaire.
The STOP-BANG questionnaire for determining OSA risk level.
An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.
Record of postoperative complications
Respiratory complications as laryngospasm/bronchospasm, apnea, hypoxia, duration and amount of need for additional oxygen support and recovery time (duration of modified aldrete score of 9 and above) will be recorded.
Group highSTOP-B
Study group including patients in the high-risk group in the assessment to be made with STOP-BANG questionnaire.
The STOP-BANG questionnaire for determining OSA risk level.
An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.
Record of postoperative complications
Respiratory complications as laryngospasm/bronchospasm, apnea, hypoxia, duration and amount of need for additional oxygen support and recovery time (duration of modified aldrete score of 9 and above) will be recorded.
Group noneASA
The study group that includes patients who are not at risk for OSA in the evaluation with the criteria recommended by the ASA.
ASA recommended criteria for determining OSA risk level.
An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.
Record of postoperative complications
Respiratory complications as laryngospasm/bronchospasm, apnea, hypoxia, duration and amount of need for additional oxygen support and recovery time (duration of modified aldrete score of 9 and above) will be recorded.
Group mildASA
Study group including patients in the mild-risk group for OSA in the evaluation with the criteria recommended by the ASA.
ASA recommended criteria for determining OSA risk level.
An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.
Record of postoperative complications
Respiratory complications as laryngospasm/bronchospasm, apnea, hypoxia, duration and amount of need for additional oxygen support and recovery time (duration of modified aldrete score of 9 and above) will be recorded.
Group moderateASA
Study group including patients in the moderate-risk group for OSA in the evaluation with the criteria recommended by the ASA.
ASA recommended criteria for determining OSA risk level.
An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.
Record of postoperative complications
Respiratory complications as laryngospasm/bronchospasm, apnea, hypoxia, duration and amount of need for additional oxygen support and recovery time (duration of modified aldrete score of 9 and above) will be recorded.
Group severeASA
Study group including patients in the severe-risk group for OSA in the evaluation with the criteria recommended by the ASA.
ASA recommended criteria for determining OSA risk level.
An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.
Record of postoperative complications
Respiratory complications as laryngospasm/bronchospasm, apnea, hypoxia, duration and amount of need for additional oxygen support and recovery time (duration of modified aldrete score of 9 and above) will be recorded.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The STOP-BANG questionnaire for determining OSA risk level.
An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.
ASA recommended criteria for determining OSA risk level.
An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.
Record of postoperative complications
Respiratory complications as laryngospasm/bronchospasm, apnea, hypoxia, duration and amount of need for additional oxygen support and recovery time (duration of modified aldrete score of 9 and above) will be recorded.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients without a previous diagnosis of OSA
Exclusion Criteria
* Patients previously diagnosed with OSA
* Necessity of emergency surgery
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TC Erciyes University
OTHER
Kırıkkale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gözde Nur Erkan
Assistant Professor Doctor, Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Erciyes University Faculty of Dentistry
Kayseri, , Turkey (Türkiye)
Kırıkkale University Faculty of Dentistry
Kırıkkale, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KU-ERKAN-002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.